From lab to clinic: the evolving translational landscape of nucleic acid therapeutics

Nucleic Acid Insights is delighted to present the latest updates in the nucleic acids field through this new Industry Update, which highlights recent preclinical and translational R&D advances across oligonucleotides, mRNA, DNA therapeutics, as well as associated formulation and delivery technologies.

This month we have insights from industry experts Jimmy Weterings (Vice President, Head of Oligonucleotide Therapeutics, Bonito Biosciences), Piotr Kowalski (Senior Lecturer in Advanced Therapies, University College Cork), Christian Ottensmeier (Professor of Immuno-oncology, University of Liverpool), and John Lewis (Chief Executive Officer, Entos Pharmaceuticals).

Please enter your email to access content Read now